Pemgarda Side Effects

Generic name: pemivibart

Note: This document contains side effect information about pemivibart. Some dosage forms listed on this page may not apply to the brand name Pemgarda.

Applies to pemivibart: intravenous solution.

The US Food and Drug Administration (FDA) has authorized emergency use of pemivibart for prevention of COVID-19 in certain adults and children at least 12 years of age who weigh at least 88 lbs (40 kg).

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection and up to 24 hours after receiving pemivibart (the active ingredient contained in Pemgarda) Tell your medical caregivers if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, swelling in your face, flushing (sudden warmth, redness, or tingly feeling), ringing in your ears, or have fast heartbeats.

Your treatment may be permanently discontinued if you have certain side effects.

Common side effects may include:

bruising, swelling, warmth, redness, oozing, or bleeding where the IV needle is placed;
feeling unwell during the injection;
flu-like symptoms, cold symptoms, viral infections;
headache, tiredness; or
nausea.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.